Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalFRA:O66 -5.84%8 Return-on-Tangible-Asset is -20.33% as of Dec. 2025. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 120 Medical Distribution companies, 160 Health International ranks worse than 91.67% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. 160 Health International's annualizedNet Income for the quarter that ended in Dec. 2025 was €-13.06 Mil. 160 Health International's average total tangible assets for the quarter that ended in Dec. 2025 was €64.25 Mil. Therefore, 160 Health International's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was -20.33%.
The historical rank and industry rank for 160 Health International's Return-on-Tangible-Asset or its related term are showing as below:
FRA:O66'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -63.2 Med: -46.42 Max: -13.97
Current: -16.25
During the past 4 years, 160 Health International's highest Return-on-Tangible-Asset was -13.97%. The lowest was -63.20%. And the median was -46.42%.
FRA:O66's Return-on-Tangible-Asset is ranked worse than 91.67% of 120
companies
in the Medical Distribution industry
Industry Median: 2.43
vs FRA:O66: -16.25
160 Health International (FRA:O66) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
160 Health International Return-on-Tangible-Asset Related Terms
160 Health International Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for 160 Health International's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
160 Health International Return-on-Tangible-Asset Chart
FRA:O66 vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, 160 Health International's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
160 Health International Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 160 Health International's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where 160 Health International's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of -20.33% mean?
160 Health International (FRA:O66) has a Return-on-Tangible-Asset of -20.33% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on 160 Health International and its competitors. According to the industry distribution chart, 160 Health International ranks #110 out of 120 companies in the Medical Distribution industry, placing it in the top 91.7%.
Is 160 Health International's Return-on-Tangible-Asset too high?
160 Health International's current Return-on-Tangible-Asset is -20.33%. Based on the distribution chart, 160 Health International ranks #110 out of 120 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Return-on-Tangible-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #110 out of 120 companies for Return-on-Tangible-Asset. This places 160 Health International in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.43, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current Return-on-Tangible-Asset is -20.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current Return-on-Tangible-Asset of -20.33%. The current Return-on-Tangible-Asset is -20.33%. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current Return-on-Tangible-Asset is -20.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for FRA:O66
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:O66 has been successfully added to your 
